Addition of Ezetimibe to Intensive Lipid-Lowering Therapy Is Associated With a Lower Incidence of Heart Failure in Patients With Acute Coronary Syndrome
Intensive lipid-lowering therapy with pitavastatin and ezetimibe is associated with a lower incidence of hospitalization for HF in patients with ACS.
Authors
- Hiroyuki Arashi (ORCID: https://orcid.org/0000-0002-5340-8603)
- Hiroshi Ogawa (ORCID: https://orcid.org/0000-0002-2576-2525)
- Eiji Shibahashi (ORCID: https://orcid.org/0000-0002-8733-7903)
- Erisa Kawada‐Watanabe (ORCID: https://orcid.org/0000-0001-9738-8475)
- Hisao Otsuki (ORCID: https://orcid.org/0000-0003-0976-1319)
- Junichi Yamaguchi (ORCID: https://orcid.org/0000-0003-0967-0978)
- Atsushi Honda
- Masafumi Yoshikawa
- Nobuhisa Hagiwara
Institutions
- Tokyo Women's Medical University Adachi Medical Center (JP)
- Tokyo Women's Medical University (JP)
- Tokyo Women's Medical University Yachiyo Medical Center
Publication Details
- Journal
- Circulation Journal
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1253/circj.cj-24-0536
- Citations
- 7
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Boston Scientific Corporation